We evaluated associations between history of syphilis infection and both cognitive function and depressive symptoms in people living with HIV (PLHIV) and comparable HIV-negative controls. Syphilis serological tests, cognitive function and depression were assessed in PLHIV and controls participating in the Pharmacokinetic and Clinical Observations in People Over Fifty study. Cognitive test scores were converted to demographically adjusted T-scores (mean ¼ 50, SD ¼ 10) and then averaged to obtain a global T-score. Severity of depressive symptoms was assessed via the Patient Health Questionnaire-9. Associations of syphilis with global T-scores and depression were assessed using median regression. The 623 PLHIV and 246 HIV-negative controls were predominantly male (89.3% and 66.5%) with median age (interquartile range ; however, the association became non-significant (p ¼ 0.62) after adjusting for HIV status and potential confounders. Despite the higher prevalence of syphilis infection in PLHIV, there was no evidence of an association between history of syphilis infection and impaired cognitive function nor depressive symptoms after accounting for potential confounders.
Introduction
In recent years syphilis has seen a resurgence with the incidence increasing after decades of decline. 1 Untreated syphilis can cause serious neurological sequelae, including cognitive and psychiatric disorders, 2 which may be more common in people living with HIV (PLHIV) and may occur earlier in the course of the infection. 3 Syphilis may be associated with cognitive impairment in PLHIV, 4 possibly as a result of higher rates of both symptomatic and asymptomatic neurological involvement in PLHIV compared to HIV-negative controls. Indeed asymptomatic neurological involvement, based on cerebrospinal fluid findings, has been reported in 22.5% versus 10% of PLHIV and HIV-negative controls, respectively, 5 as well as an increased use of single-dose benzathine penicillin for the treatment of early syphilis, which may not be as effective as other therapies in clearing treponema from the central nervous system. 6 However, the contribution, if any, of past syphilis to cognitive impairment and depressive symptoms reported in PLHIV remains unclear as previous studies have not fully controlled for lifestyle factors that may confound any relationships with past syphilis, which may be a marker of risktaking behaviour. Here, we sought to determine the relationships between past syphilis infection and both cognitive function and depressive symptoms in a cohort of PLHIV representative of people attending for care in the UK, as well as in demographically comparable HIV-negative controls. Our hypothesis was that HIV infection would modify the relationship between syphilis and cognitive function with past infection of syphilis being associated with poorer cognitive function and more depressive symptoms in PLHIV.
Methods

Study design and participants
The Pharmacokinetic and Clinical Observations in People Over Fifty (POPPY) study recruited a cohort of PLHIV aged over 50 years as well as control cohorts of younger PLHIV aged under 50 years and demographically comparable HIV-negative people aged over 50 years from HIV clinics, sexual health clinics and targeted community groups as described previously. 7 Inclusion criteria for the groups of PLHIV were documented presence of HIV infection, self-defined white or black-African ethnicity, likely route of HIV acquisition via sexual exposure (either by male-to-male exposure if white or by heterosexual exposure if white or black-African) and the ability to comprehend the study patient information leaflet. The two control groups were frequency-matched on gender, ethnicity, sexual orientation and location (in or out of London) to the group of older PLHIV (with the control group of HIV-negative people additionally frequency-matched for age). The study was approved by the UK National Research Ethics Service (NRES; Fulham London, UK number 12/LO/1409). All participants provided written informed consent. The present analyses used information from the baseline POPPY visit only and included only the two older cohorts.
Definition of syphilis infection
Results of Treponema pallidum particle agglutination test (TPPA), rapid plasma reagin (RPR) test and selfreported history of syphilis were combined to define past and possible current syphilis infection as detailed in Table 1 . Serology was undertaken locally at each POPPY clinical site with the screening algorithms dependent on local practice. Briefly, a history of syphilis infection was defined as either a positive TPPA or a positive RPR test confirmed by a self-reported history of syphilis. A negative TPPA and/or RPR and a negative TPPA with a positive RPR but without a self-reported history of syphilis were considered as indicative of no history of syphilis infection.
Assessment of cognitive function and depressive symptoms
Assessment of cognitive function was performed using the CogState TM (Melbourne, Australia) battery, 8 a computerised battery that has been previously used in cohorts of PLHIV. 9, 10 The assessment covered six cognitive domains, as described previously 11 and summarised in supplementary material. Quality checks were applied to ensure that scores were generated from completed and fully understood tasks for each subject. Individual test scores were transformed as appropriate and converted into T-scores (mean of 50 and standard deviation of 10) accounting for age, gender, ethnicity and level of education, using the HIV-negative control group as the reference population. A global T-score was calculated by averaging individual domain T-scores with higher values indicating better cognitive function.
Depressive symptoms were evaluated using the Patient Health Questionnaire-9 (PHQ-9), the recommended tool for the assessment of depression in PLHIV, 12 with scores ranging from 0 (no depression) to 27 (severe depression). 13 
Statistical analysis
Pairwise group comparisons of socio-demographic and self-reported lifestyle characteristics between older PLHIV and similarly aged HIV-negative controls and between those with a history of syphilis and those without were assessed using Chi square and Wilcoxon ranksum tests as appropriate. The independent effects of syphilis and HIV status (also independent of potential confounders) on both outcomes were evaluated using median regression models to minimise the influence of large outliers. Socio-demographic and lifestyle factors were included as potential confounders if they were significantly associated with the outcome (cognitive scores or depressive symptoms) and with a history of syphilis infection. Factors considered included age, gender, ethnicity, level of education, sexuality, self-reported smoking, alcohol consumption and recreational drug use in the past six months. We also evaluated interactions between syphilis infection and HIV status, to test whether the associations between syphilis and each outcome differed across PLHIV and HIVnegative controls. All analyses were performed using SAS v9.4 with p-values <0.05 considered as statistically significant. with HIV RNA <50 copies/ml) and 248 HIVnegative controls were comparable in terms of age and smoking status (Table 2) . However, PLHIV were more likely to be male, men who have sex with men and to have reported recreational and injected drug use but less likely to be current consumers of alcohol compared to HIV-negative controls. Table 2 ). A total of 137 (22.0%) PLHIV and 20 (8.1%) HIV-negative controls had a history of syphilis infection, with a significantly higher prevalence among PLHIV than HIV-negative individuals (p < 0.001).
Results
Participant characteristics
Cognitive function
The median (IQR) global T-score was 48.4 (44.9, 52.1) and 49.4 (45.7, 52.8) in those with a history of syphilis and those without, respectively (p ¼ 0.09, Table 2 
Depressive symptoms
Participants with a history of syphilis reported a 2.0 (0.7, 3.3) points higher median PHQ-9 score than participants without (p ¼ 0.03, Table 2 ). After adjusting for HIV status, the difference (95% CI) remained but was smaller: 1.0 (0.2, 1.8), p ¼ 0.02. However, after adjustment for potential confounders (alcohol consumption, smoking, recreational and injected drug use) the magnitude of the difference (95% CI) was further reduced and was no longer statistically significant: 0.1 (À1.0, 1.0), p ¼ 0.62. There was no difference in depressive symptoms within both groups (p ¼ 0.68 and p ¼ 0.27 in PLHIV and HIV-negative controls, respectively, Figure 1(b) ), and no interaction between history of syphilis infection, HIV status and depressive symptoms (p ¼ 0.47).
Discussion
Despite the increased prevalence of syphilis infection in PLHIV, we did not find an association between past or possible current infection and impaired cognitive function nor depressive symptoms after accounting for potential confounders. Moreover, we did not find that HIV status modified the relationships between current history of syphilis and cognitive function or depressive symptoms. These data are important as, to our knowledge, this is the largest study of syphilis and cognitive function in PLHIV. A previous study from the CHARTER cohort compared cognitive function in 82 PLHIV with previous syphilis and 52 who had never been infected with syphilis. 4 Those with prior syphilis did not have higher rates of depressive symptoms. However, past syphilis was associated with a higher global deficit score and a higher rate of impairment in the learning domain. This contrasts with our findings, but it should be noted that the association with impairment in learning was attenuated after accounting for methamphetamine use and between those with and without current/past syphilis were performed in PLHIV only (n with past or current syphilis ¼ 137).
was no longer statistically significant. The large sample size in our study, comprehensive assessment and recruitment of demographically comparable HIV-negative controls allowed adjustment for potential confounders that may have exaggerated differences in cognitive function previously observed 4 between those who did and did not have a history of syphilis infection. Other unmeasured confounders (e.g. highrisk sexual behaviours) may exist between PLHIV and controls; however, it is unlikely that these would act in the opposite direction of the confounders we considered. It should be noted that the definition of syphilis we used was fairly conservative, in that participants who were RPR positive but reported no prior history of syphilis were not considered to have syphilis, given our study population. However, only one HIVpositive participant was RPR positive without reporting prior history of syphilis and it is therefore unlikely that this resulted in a substantial bias. Moreover, whilst worse cognitive function and depressive symptoms could have been observed in participants with current syphilis compared to those with past syphilis or no history of syphilis, the small number of participants who may have had current syphilis infection (a maximum of 27 PLHIV and 3 HIV-negative participants if possible current syphilis is assumed in those with either a positive RPR and TPPA or a positive RPR confirmed by a self-reported history of syphilis when TPPA was not done) did not permit full investigations of these associations. We do not have data on the full treatment histories of syphilis to confirm if these individuals truly had untreated early syphilis or prior treated syphilis with persistent non-treponemal titres (sero-fast RPR). Of note, a sensitivity analysis, in which individuals with possible current syphilis were excluded, yielded results that were comparable to the main results presented here (data of the sensitivity analysis not shown).
In addition, whilst almost all PLHIV considered were on successful antiretroviral therapy (99% on treatment, 93% with a HIV RNA <50 copies/ml) reflecting current epidemics in UK and Ireland, 14 those not optimally treated and hence potentially with worse cognitive function and higher rates of syphilis infection may be less represented in our study. Similarly, our findings were obtained in individuals aged over 50 years, so results cannot be generalised to younger cohorts of PLHIV. As described above, an important limitation is the lack of accurate syphilis staging and treatment history. However, even if individuals with neurological involvement from syphilis received syphilis therapy not considered optimal for neurosyphilis, we would expect this to have increased the effect size observed and increased the presence of any neurological sequelae. Whilst syphilis can contribute to several psychiatric disorders, 15 we only focused on depressive symptoms as depression is the most common psychiatric disorder in PLHIV. 16 Furthermore, the cross-sectional nature of our analyses limits our ability to establish temporal associationsfuture longitudinal analyses of this cohort may provide further insight to the impact of past syphilis infection on changes in cognitive function and new-onset depressive symptoms.
In summary, in this large cohort of PLHIV and HIV-negative controls we did not find evidence that a history of syphilis was independently associated with impaired cognitive function or depressive symptoms. 
